Internal Medicine, Infectious Disease · Miami, FL
NPI
1780681361
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3661 S Miami Ave, Ste 108
Miami, FL, 33133
Phone (305) 858-3900
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
408 services
Medicare patients, 2024
59
Average age 64
Drug cost, 2024
$8.9M
5,928 prescriptions
Company payments, 2025
$667
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vanessa I Silebi was code 99214 (office e&m - established), 267 times for 57 patients. In total Vanessa I Silebi billed 408 services in 6 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 267 | 57 | $98.89 | $26K |
| 99213 Office E&M - Established | Office | 115 | 44 | $64.59 | $7,428 |
By year: 2022 $29K for 632 services; 2023 $28K for 348 services; 2024 $34K for 408 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vanessa I Silebi prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 801 prescriptions and refills. In total Vanessa I Silebi wrote 5,928 Medicare prescriptions that cost $8.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 801 | 811 | 82 | $3.3M |
| Vascepa Icosapent Ethyl | 172 | 200 | 22 | $69K |
| Serostim Somatropin | 157 | 166 | 13 | $3.3M |
| Alprazolam Generic | 136 | 140 | 18 | $706 |
| Ketoconazole Generic | 133 | 138 | 16 | $2,801 |
| Ibuprofen Generic | 132 | 169 | 23 | $1,289 |
| Acyclovir Generic | 111 | 131 | 15 | $3,786 |
| Valacyclovir Valacyclovir Hcl | 111 | 145 | 19 | $4,654 |
| Atorvastatin Calcium Generic | 108 | 204 | 20 | $538 |
| Diclofenac Sodium Generic | 102 | 102 | 16 | $1,512 |
| Metformin Hcl Generic | 92 | 150 | 17 | $267 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 91 | 91 | Under 11 | $433K |
| Rosuvastatin Calcium Generic | 89 | 138 | 16 | $784 |
| Meloxicam Generic | 89 | 91 | 16 | $189 |
| Lisinopril Generic | 87 | 145 | 13 | $510 |
Brand drugs: 2,023 claims; generic drugs: 3,855 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vanessa I Silebi $667 ($667 in general payments such as food, travel and fees) from 4 companies. The largest payer was Gilead Sciences, Inc. with $318.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.